Purchase Order 75N92019P00344

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on December 8, 2014, for multi-year maintenance services on a BD FACSAria II special cell sorter system, with a ceiling value of $302,184.00 and firm fixed pricing. The order runs through ultimate completion on December 17, 2019. Place of performance is Bethesda, Maryland. The purchase order covers maintenance services for the flow cytometry core facility's BD...

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $29,376.00 on February 10, 2015, with an ultimate completion date of March 14, 2016. The order covers a FACSARIA II special order system maintenance agreement, priced on a firm fixed price basis with no set-aside. Work is performed at Bethesda, Maryland. This is a commercial item procurement for flow cytometry system maintenance, consistent with BD Biosciences'...

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on July 10, 2012, for $24,570.00 to provide a maintenance agreement for a BD FACSAria II flow cytometer. Performance takes place in Bethesda, Maryland. The contract carries a firm fixed price and ultimate completion date of August 29, 2013. The FACSAria II is a complex flow cytometer sorter with specialized fluidics and unique electronic circuit boards requiring ongoing...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on March 15, 2022, for BD FACSAria II flow cytometer sorter maintenance services, with a ceiling value of $38,718.00 and an ultimate completion date of March 14, 2023. Work is performed in San Jose, California. The procurement was issued on full and open competition with no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences) on March 15, 2020, for BD Biosciences Aria II Flow Cytometer maintenance services, with a ceiling value of $32,562.00 and firm fixed pricing. Performance occurs in Bethesda, Maryland, with an ultimate completion date of March 14, 2021. No set-aside applied to this acquisition.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on November 1, 2019, for BD FACSymphony maintenance services with a ceiling value of $31,608.94. Performance is firm fixed price with an ultimate completion date of September 30, 2020. Place of performance is Bethesda, Maryland. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to BD Biosciences for $29,376.00 on February 27, 2014, for one year of maintenance on a FACSAria II flow cytometer located at the NHLBI Division of Intramural Research in Bethesda, Maryland. Work is scheduled for completion by March 14, 2015. This is a firm fixed-price commercial purchase with no set-aside used.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on December 20, 2016, with a ceiling value of $29,795.40 for maintenance services. The order is firm fixed price with no set-aside. Place of performance is Bethesda, Maryland. Ultimate completion date is January 31, 2018.</p>

The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on November 20, 2015, with a ceiling value of $15,413.40 for service contract support related to BD FACSCanto flow cytometry instrumentation. The order ran from October 1, 2015, through September 30, 2016, at the place of performance in Bethesda, MD. Pricing was firm fixed price with no set-aside applied. The order was issued on a full-and-open basis to the...

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for an LSRFortessa multi-year maintenance agreement with a ceiling value of $283,987.80, awarded November 17, 2014, with ultimate completion November 20, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. This is a maintenance agreement supporting flow cytometry instrumentation at a federal research facility, typical of BD...